Picture of Rohto Pharmaceutical logo

4527 — Rohto Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Table: Rohto - 6-MTH group results

Nov 10 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              110.31               91.02           230.00    
                   (+21.2 pct)                          (+15.2 pct) 
  Operating           16.27               13.75            31.00    
                   (+18.3 pct)                          (+6.8 pct)  
  Recurring           17.96               13.50            32.00    
                   (+33.1 pct)                          (+11.3 pct) 
  Net                 13.19               11.02            22.00    
                   (+19.7 pct)                          (+4.1 pct)  
  EPS              115.65 yen           96.63 yen        96.43 yen  
  EPS Diluted      115.32 yen           96.35 yen                   
  Ann Div                               36.00 yen                   
  -Q2 div           20.00 yen           15.00 yen                   
  -Q4 div                               21.00 yen        10.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T

Recent news on Rohto Pharmaceutical

See all news